AOD9604 is an orally active, lipolytic peptide fragment of human growth hormone and derivative of the C-terminal domain of human growth hormone (HGH).
AOD-9604 is a peptide fragment of human growth hormone that is marketed for weight management by targeting fat metabolism. It is designed to stimulate the breakdown of fat, known as lipolysis, and inhibit the formation of new fat cells (lipogenesis).